Home pageInternational cooperationVaccinal Nanovector approach for prophylaxis or treatment...

Vaccinal Nanovector approach for prophylaxis or treatment of an allergy

Date: 22.9.2014 

Technology offer: Vaccinal Nanovector approach for prophylaxis or treatment of an allergy  

Reference: 13 FR 34k3 3SOB

Summary: A French research Institute has developed new class of lipid vector for intracellular vaccination using DNA molecule coding for the antigen of asthma. The aim is to produce a prophylactic or therapeutic vaccine. The vaccine administration in animal model led to a reduction of airway hyperresponsiveness and a significant decrease of inflammatory cytokines in the bronchoalveolar lavage. Industrial partners are sought in order to co-develop asthma and rhinitis allergy applications.

For more information click here.


Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.


 

OPPI, MPO, EU

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist